Robust CYP2D6 genotype assay including copy number variation using multiplex single-base extension for Asian populations

被引:19
作者
Kim, Eun-Young [2 ]
Lee, Sang-Seop [1 ]
Jung, Hyun-Ju [1 ]
Jung, Hye-Eun [1 ]
Yeo, Chang-Woo [1 ]
Shon, Ji-Hong [1 ,2 ]
Shin, Jae-Gook [1 ,2 ]
机构
[1] Inje Univ, Coll Med, Dept Pharmacol & Pharmacogenom, Res Ctr, Pusan 614735, South Korea
[2] Inje Univ, Busan Paik Hosp, Dept Clin Pharmacol, Pusan, South Korea
关键词
CYP2D6; Multiplex SBE; Korean; Asian; Polymorphism; CNV; GENETIC POLYMORPHISMS; VARIANTS; PHARMACOGENOMICS; CONSEQUENCES; CYP2C19;
D O I
10.1016/j.cca.2010.08.042
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: We developed a CYP2D6 genotyping method that includes copy number variation (CNV) and recently known functional haplotypes using multiplex single-base extension (SBE). Methods: Twelve CYP2D6 alleles (*1, *2, *5, *10, *14, *18, *21, *41, *49, *52, *60, and a duplication of CYP2D6) were genotyped using 2 PCR reactions followed by multiplex SBE with 10 primers and singleplex SBE with 1 primer. The result from 758 Korean samples was validated by comparison with the results of direct sequencing or other genotyping methods. We also genotyped 89 Chinese and 122 Vietnamese subjects to determine the presence of recently identified functional alleles. Results: All 12 CYP2D6 alleles, including gene deletion and duplication, were obviously discriminated. The concordance rate was 100% between our method and other methods. Our method also covered over 98% of the CYP2D6 genotypes in Japanese and Chinese subjects based on reported data. In addition to published genotypes, *14, *21, *41, *49, and *52 were found in about 5% in Chinese and Vietnamese. Conclusions: The CYP2D6 genotyping method may be clinically applicable for Asian populations. The method can be improved easily to cover other ethnic groups by utilizing additional haplotype tagging SNPs. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:2043 / 2048
页数:6
相关论文
共 20 条
[1]   Interethnic differences in genetic polymorphisms of CYP2D6 in the US population: Clinical implications [J].
Bernard, Stephen ;
Neville, Kathleen A. ;
Nguyen, Anne T. ;
Flockhart, David A. .
ONCOLOGIST, 2006, 11 (02) :126-135
[2]   Molecular genetics of CYP2D6:: Clinical relevance with focus on psychotropic drugs [J].
Bertilsson, L ;
Dahl, ML ;
Dalén, P ;
Al-Shurbaji, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (02) :111-122
[3]   Moving towards individualized medicine with pharmacogenomics [J].
Evans, WE ;
Relling, MV .
NATURE, 2004, 429 (6990) :464-468
[4]   Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data [J].
Gaedigk, A ;
Gotschall, RR ;
Forbes, NS ;
Simon, SD ;
Kearns, GL ;
Leeder, JS .
PHARMACOGENETICS, 1999, 9 (06) :669-682
[5]   Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity [J].
Ingelman-Sundberg, M .
PHARMACOGENOMICS JOURNAL, 2005, 5 (01) :6-13
[6]   Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment [J].
Ingelman-Sundberg, M ;
Oscarson, M ;
McLellan, RA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (08) :342-349
[7]  
Ji L, 2002, CHINESE MED J-PEKING, V115, P1780
[8]   Efficient selective screening of haplotype tag SNPs [J].
Ke, XY ;
Cardon, LR .
BIOINFORMATICS, 2003, 19 (02) :287-288
[9]   Duplex pyrosequencing assay of the 388A>G and 521T>C SLCO1B1 polymorphisms in three Asian populations [J].
Kim, Eun-Young ;
Cho, Doo-Yeoun ;
Shin, Ho-Jung ;
Lee, Sang-Seop ;
Shon, Ji-Hong ;
Shin, Jae-Gook ;
Shin, Sang-Goo .
CLINICA CHIMICA ACTA, 2008, 388 (1-2) :68-72
[10]   Comparisons of CYP2C19 genetic polymorphisms between Korean and Vietnamese populations [J].
Lee, Sang Seop ;
Lee, Su-Jun ;
Gwak, Jungsug ;
Jung, Hyun-Ju ;
Thi-Le, Houng ;
Song, Iin-Sook ;
Kim, Eun-Young ;
Shin, Jae-Gook .
THERAPEUTIC DRUG MONITORING, 2007, 29 (04) :455-459